MIRM – mirum pharmaceuticals, inc. - common stock (US:NASDAQ)
Stock Stats
News
2/5
08:51 am
mirm
Medium
Mirum Pharmaceuticals Announces Health Canada Authorization of LIVMARLI® Tablet Formulation for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome
2/5
08:00 am
mirm
Medium
Mirum Pharmaceuticals Announces Health Canada Authorization of LIVMARLI® for the Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC)
2/3
07:17 am
mirm
Low
Mirum doubles down on diversified rare disease strategy [Yahoo! Finance]
1/31
03:29 pm
mirm
Low
Is Mirum Pharmaceuticals on a Strong Path to Profitability? [Yahoo! Finance]
1/30
12:26 pm
mirm
Low
Mirum Pharmaceuticals (NASDAQ:MIRM) had its price target raised by analysts at Morgan Stanley from $95.00 to $123.00. They now have an "overweight" rating on the stock.
11/4/2025
04:01 pm
mirm
-1.2%
BEAT
8/6/2025
04:01 pm
mirm
12.0%
BEAT
5/7/2025
04:01 pm
mirm
9.8%
BEAT
1/30
12:04 pm
Maintains
Overweight
Overweight
Morgan Stanley
Low
0.9%
1/30
12:04 pm
Maintains
Overweight
Overweight
Morgan Stanley
Low
0.9%
1/20
09:05 am
Reiterates
Outperform
Outperform
Evercore ISI
Low
1.1%
1/20
09:05 am
Reiterates
Outperform
Outperform
Evercore ISI
Low
1.1%
1/13
07:17 am
Reiterates
Buy
Buy
HC Wainwright
Low
-0.3%
2/3
09:45 pm
mirm
Low
Form 4 Mirum Pharmaceuticals, For: Feb 02 Filed by: Radovich Peter
2/3
09:45 pm
mirm
Low
Form 4 Mirum Pharmaceuticals, For: Feb 02 Filed by: Peetz Christopher
2/3
09:45 pm
mirm
Low
Form 4 Mirum Pharmaceuticals, For: Jan 31 Filed by: Howe Jolanda
2/2
08:29 pm
mirm
Low
Form 144 Mirum Pharmaceuticals, Filed by: Howe Jolanda
2/2
08:26 pm
mirm
Low
Form 144 Mirum Pharmaceuticals, Filed by: Radovich Peter
Show more
Top News Gainers
12/13 Mirum Pharmaceuticals to Provide Regulatory Update in Upcoming Conference Call and Webcast 111.0%
3/23 Form 4 Mirum Pharmaceuticals, For: Mar 19 Filed by: Tucker Edwin Jonathan 20.8%
3/12 Form 10-K Mirum Pharmaceuticals, For: Dec 31 16.2%
1/16 Frazier Healthcare Partners Closes Oversubscribed $617 Million Life Sciences Fund 15.2%
12/7 Mirum Pharmaceuticals (NASDAQ: MIRM) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 11.2%
4/17 Mirum Pharmaceuticals (NASDAQ: MIRM) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 6.0%
4/28 Mirum Pharmaceuticals Appoints Peter Radovich as Chief Operating Officer 5.5%
4/30 Form 3 Mirum Pharmaceuticals, For: Apr 28 Filed by: Radovich Peter 5.4%
2/18 Mirum Pharmaceuticals to Participate at Four Upcoming Conferences 5.0%
4/9 Mirum Pharmaceuticals (NASDAQ: MIRM) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $15.00 price target on the stock. 4.7%
Top News Decliners
3/17 Mirum Pharmaceuticals (MIRM) Investor Presentation - Slideshow [Seeking Alpha] -10.7%
1/8 Mirum Pharmaceuticals Announces Pricing of Public Offering -6.6%
1/6 Form S-1 Mirum Pharmaceuticals, -6.0%
12/17 Mirum Pharmaceuticals (NASDAQ: MIRM) had its price target raised by analysts at Citigroup Inc from $21.00 to $30.00. They now have a "buy" rating on the stock. -5.8%
4/16 Mirum Pharmaceuticals (NASDAQ: MIRM) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $17.00 price target on the stock. -5.6%
1/9 Form 424B4 Mirum Pharmaceuticals, -5.0%
8/28 Mirum Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update -4.8%
8/12 Mirum Pharmaceuticals (NASDAQ: MIRM) is now covered by analysts at Citigroup Inc. They set a "buy" rating on the stock. -4.6%
12/28 Mirum Pharmaceuticals (NASDAQ: MIRM) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -4.4%
9/26 Mirum Pharmaceuticals to Present at Cantor 2019 Global Healthcare Conference -3.9%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3